Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing Transplantation
- Status
- COMPLETED
- Phase
- NA
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of Immunomaintenance Using POmalidomide With Elotuzumab afteR Second Autologous Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or Subcutaneous (SC) Bortezomib and Oral Dexamethasone Tablet and to Assess Change in Disease Symptoms in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study of Autologous Natural Killer Cells in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM)
- Status
- COMPLETED
- Phase
- PHASE1
MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin
- Status
- TERMINATED
- Phase
- PHASE3
The clonoSEQ® Watch Registry
- Status
- TERMINATED
- Phase
- N/A
A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.
- Status
- RECRUITING
- Phase
- NA
Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1